Abstract
Background
Magnetic sphincter augmentation (MSA) is an effective treatment for gastroesophageal reflux disease (GERD). However, the impact of obesity on MSA outcomes is unknown. The objective of this study was to evaluate the effectiveness of MSA in patients with GERD and obesity.
Methods
A retrospective cohort study was performed of consecutive patients who underwent laparoscopic MSA at three high-volume centers from 2016 to 2019. Patients were grouped into four cohorts according to the World Health Organization body mass index (BMI) classification: BMI < 25 (normal weight), BMI 25–29.9 (overweight), BMI 30–34.9 (obese class I), and BMI > 35 (obese class II–III). Preoperative, operative, and postoperative data were compared between groups.
Results
A total of 621 patients underwent laparoscopic MSA during the study period. Follow-up with endoscopy or video esophagram was available for 361 patients (58%) with a median follow-up of 15.4 months. Baseline characteristics of the groups were similar except the BMI > 35 group had more females and a higher preoperative median DeMeester score. There were no significant differences in outcomes between normal weight, overweight, and obese patient groups undergoing MSA. All groups experienced significant reductions in acid suppressive medication use, low GERD-HRQL scores, low DeMeester scores, few intraoperative and postoperative complications, and low rates of hiatal hernia recurrence after MSA.
Conclusions
Magnetic sphincter augmentation is safe and effective in improving GERD symptoms, reducing esophageal acid exposure, and preventing hiatal hernia recurrence, irrespective of patient BMI. MSA should be considered an acceptable treatment option for obese patients with GERD.
Similar content being viewed by others
References
Richter JE, Rubenstein JH (2018) Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology 154:267–276
Hales CM, Carroll MD, Fryar CD, Ogden CL, Ph D (2020) Prevalence of obesity and severe obesity among adults. CDC, pp 1–7
Barak N, Ehrenpreis ED, Harrison JR, Sitrin MD (2002) Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations. Obes Rev 3:9–15
Hampel H, Abraham NS, El-Serag HB (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143:199
Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ (2006) Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 130:639–649
Perez AR, Moncure AC, Rattner DW (2001) Obesity adversely affects the outcome of antireflux operations. Surg Endosc 15:986–989
Morgenthal CB, Lin E, Shane MD, Hunter JG, Smith CD (2007) Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc 21:1978–1984
Tekin K, Toydemir T, Yerdel MA (2012) Is laparoscopic antireflux surgery safe and effective in obese patients? Surg Endosc 26:86–95
Winslow ER, Frisella MM, Soper NJ, Klingensmith ME (2003) Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS). Surg Endosc 17:2003–2011
D’Alessio MJ, Arnaoutakis D, Giarelli N, Villadolid DV, Rosemurgy AS (2005) Obesity is not a contraindication to laparoscopic Nissen fundoplication. J Gastrointest Surg 9:949–954
Chisholm JA, Jamieson GG, Lally CJ, Devitt PG, Game PA, Watson DI (2009) The effect of obesity on the outcome of laparoscopic antireflux surgery. J Gastrointest Surg 13:1064–1070
Luketina RR, Koch OO, Köhler G, Antoniou SA, Emmanuel K, Pointner R (2015) Obesity does not affect the outcome of laparoscopic antireflux surgery. Surg Endosc 29:1327–1333
Anvari M, Bamehriz F (2006) Outcome of laparoscopic Nissen fundoplication in patients with body mass index ≥35. Surg Endosc 20:230–234
Reynolds JL, Zehetner J, Nieh A, Bildzukewicz N, Sandhu K, Katkhouda N, Lipham JC (2016) Charges, outcomes, and complications: a comparison of magnetic sphincter augmentation versus laparoscopic Nissen fundoplication for the treatment of GERD. Surg Endosc 30:3225–3230
Saino G, Bonavina L, Lipham JC, Dunn D, Ganz RA (2015) Magnetic sphincter augmentation for gastroesophageal reflux at 5 years: final results of a pilot study show long-term acid reduction and symptom improvement. J Laparoendosc Adv Surg Technol 25:787–792
Ferrari D, Asti E, Lazzari V, Siboni S, Bernardi D, Bonavina L (2020) Six to 12-year outcomes of magnetic sphincter augmentation for gastroesophageal reflux disease. Sci Rep 10:1–9
Ganz RA, Peters JH, Horgan S et al (2013) Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med 368:719–727
Korolija D, Sauerland S, Wood-Dauphinée S et al (2004) Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for endoscopic surgery. Surg Endosc 18:879–897
Velanovich V (2007) The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 20:130–134
Reynolds JL, Zehetner J, Wu P, Shah S, Bildzukewicz N, Lipham JC (2015) Laparoscopic magnetic sphincter augmentation vs laparoscopic nissen fundoplication: a matched-pair analysis of 100 patients. J Am Coll Surg 221:123–128
Rona KA, Reynolds J, Schwameis K et al (2017) Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias. Surg Endosc 31:2096–2102
Tatum JM, Samakar K, Bowdish ME, Mack WJ, Bildzukewicz N, Lipham JC (2018) Videoesophagography versus endoscopy for prediction of intraoperative hiatal hernia size. Am Surg 84:387–391
Warren HF, Reynolds JL, Lipham JC, Zehetner J, Bildzukewicz NA, Taiganides PA, Mickley J, Aye RW, Farivar AS, Louie BE (2016) Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc 30:3289–3296
Ayazi S, Zheng P, Zaidi AH, Chovanec K, Salvitti M, Newhams K, Hoppo T, Jobe BA (2020) Clinical outcomes and predictors of favorable result after laparoscopic magnetic sphincter augmentation: single-institution experience with more than 500 patients. J Am Coll Surg 230:733–743
Dunn CP, Zhao J, Wang JC, Patel TA, Putnam LR, Eka A, Houghton CC, Bildzukewicz NA, Lipham JC (2020) Magnetic sphincter augmentation with hiatal hernia repair: long term outcomes. Surg Endosc 35:3–8
Buckley FP, Bell RCW, Freeman K, Doggett S, Heidrick R (2018) Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation. Surg Endosc 32:1762–1768
Ayazi S, Chowdhury N, Zaidi AH, Chovanec K, Komatsu Y, Omstead AN, Zheng P, Hoppo T, Jobe BA (2020) Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence. Surg Endosc 34:1835–1846
Funding
No funding was obtained for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Dr. John C. Lipham is a consultant for Ethicon. Dr. Nikolai A. Bildzukewicz is a consultant for Ethicon, Intuitive, and Absolutions. Dr. Reginald Bell is a consultant for Ethicon, Intuitive, and BD. Drs. Tayler J. James, Jocelyn F. Burke, Luke R. Putnam, and Jennifer Pan have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
James, T.J., Burke, J.F., Putnam, L.R. et al. Loosening the belt on magnetic sphincter augmentation indications: does body mass index matter?. Surg Endosc 36, 4878–4884 (2022). https://doi.org/10.1007/s00464-021-08839-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-021-08839-7